Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05981911 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05981911 · ClinicalTrials.gov record · last posted 2026-01-02

Evaluation of Effectiveness and Safety of Xience Skypoint Stents in Routine Clinical Practice

Study acronym: IRIS Skypoint
StatusRecruiting
PhaseNot specified
Started2023-12-14
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 2, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
The objective of this study is to evaluate the effectiveness and safety of XIENCE Skypoint stents in comparison to other drug-eluting stents (DES) in real-world practice.

Amendment record 3 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 3 times since 2023-08-01; most recent amendment 2025-12-28. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2023-12-22
Status change Not Yet Recruiting→Recruitingv1
Trial Details
NCT Number NCT05981911
Lead Sponsor Seung-Jung Park
Collaborators: CardioVascular Research Foundation, Korea
Conditions Coronary Artery Disease
Enrollment 2,000 participants
Start Date 2023-12-14
Primary Completion 2026-06 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-02